Equipment

WuXi STA’s new high-potency injectable line has an annual capacity of 12 million units.

The bioreactor scaler tool helps scaling between development and manufacturing and to de-risk scaling activities and ensure product quality.

The new excipients manufacturing facility is expected to be completed in 2025.

This will allow industry leaders to make and sell the product, in addition to providing more choice to pharma and biotech companies.

WuXi Biologics is expanding its manufacturing capacity for drug substance and drug product at its sites in Leverkusen and Wuppertal, Germany.

Felicity Thomas, European/Senior Editor, Pharm Tech Group, and Andy Dumelow, Head of Technical Sales, I Holland, chat about tablet tooling maintenance in this brief podcast.

ProBioGen’s Lenti.RiGHT is a lentivirus production platform for use in gene transfer applications.

A good understanding of tablet tooling and how to properly maintain these key parts will maximize lifespan of tools.

The market potential of nucleic acid-based therapies have been pushed into the spotlight following the success of the COVID-19 vaccines.

Gregor Kawaletz, head of Oral Solid Dose Business Unit at Recipharm, discusses the immediate future of oral biologics

Alternative approaches to freeze-drying are gaining popularity and will help to overcome some of the challenges associated with conventional lyophilization.

Decreasing vein to vein time saves lives.

Sartorius BIA Separations and Teknova will collaborate to combine their technologies in an effort to streamline the downstream purification process.

Shifts in pharmaceutical packaging have spurred tremendous growth in the pre-filled syringe fill/finish industry.

The trends shaping the growth of the biologics outsourcing industry demand attention.

To prepare for emerging mRNA technologies, it is necessary to adapt fill/finish and cold chain capabilities.

In addition, personnel, equipment, and facilities from the acquired companies will expand Reaction Biology’s presence in Germany while enabling its global customers to leverage Bioassay’s expansive portfolio of regulated clinical and commercial services.

Overall industry growth conceals growing numbers of smaller, faster-paced, adaptable corporate structures.

Scorpion’s new facility is designed for the development and manufacturing of clinical and commercial-scale biologic drugs.

Data analytics, modular equipment, digital tools, and risk-based validation improve speed, flexibility, and quality.

Steriline will be exhibiting its vial filling and capping machine (VFCM100) under double-wall isolator for aseptic filling at CPHI 2022 in Frankfurt, Germany, on Nov. 1–3, 2022.

Documentation is crucial to equipment qualification, says Siegfried Schmitt, vice president, Technical at Parexel.

In this episode, Alivia Leon, assistant editor, speaks with Christian Dunne, director of global corporate business development, Chargepoint Technology, about current and future processing equipment trends, such as automation, cost, and sustainability.

Recipharm’s new high speed filling line, designed for pre-filled syringes and cartridges, is expected to be operational by May 2023.

Product safety and security are paramount when it comes to container closures.